Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 817-668-1 | CAS number: 667899-24-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- RA study
- Justification for type of information:
- Refer to the section 13 of IUCLID dataset for details on the read across justification. The combined repeat dose-reproductive developmental screening toxicity study with the read across substance is considered sufficient to fulfil the information requirements as further explained in the provided endpoint summary.
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CHARLES RIVER LABORATORIES JAPAN, INC. Atsugi breeding center
- Age at study initiation: (P) 10 wks- Weight at study initiation: (P) Males: 330.8-420.4 g; Females: 207.2-245.0 g
- Housing: 2 animals per cage at mating
- Diet: ad libitum
- Water: ad libitum- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0-25.0
- Humidity (%): 40.0-75.0
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hrs. dark/12 hrs light - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on mating procedure:
- - M/F ratio per cage: 1/1- Length of cohabitation: up to 2 weeks- Proof of pregnancy: vaginal plug and/or sperm in vaginal smear referred to as Day 0 of pregnancy
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Concentration of test substance was analyzed by GC method (mean content 107-110%)
- Duration of treatment / exposure:
- 42 days for males and 42-54 days for females
- Frequency of treatment:
- Once daily
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 12 animals (5 animals for satelite groups)
- Control animals:
- yes, concurrent vehicle
- Positive control:
- Not applicable
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily during breeding period and recovery period, twice daily during dosing
DETAILED CLINICAL OBSERVATIONS: Yes- Time schedule: once a week
BODY WEIGHT: Yes
- Time schedule for examinations: for males weekly and at necropsy, for females weekly during dosing and on Days 0, 7, 14 and 20 of gestation and on Days 0 and 4 of lactation and at necropsy - Oestrous cyclicity (parental animals):
- Mean time of estrous cycle and incidence of animals with estrous cycle other than a 4 day cycle per dose was determined beginning at the start of dosing until confirmation of mating.
- Sperm parameters (parental animals):
- Not applicable
- Litter observations:
- Number of (live) pups and sex ratio on Days 0 and 4.
- Postmortem examinations (parental animals):
- SACRIFICE- Male animals: Animals were sacrificed 43 days after satrting dosing or 16 days after starting recovery period. - Maternal animals: Animals were sacrificed 15 days after starting lactation. Animals that did not deliver were saclificed 26 days after pregnancy. For satelite group, sacrifice was done 15 days after starting recovery period.
- Postmortem examinations (offspring):
- Not applicable
- Statistics:
- Fisher’s exact test (significance level: 5%) was performed on the function test results, on the incidence of animals showing changes in estrous cycle, on the copulation rate, on the impregnation rate and on the incidence of morphological abnormalities in the offspring.Among the histopathological findings in the test substance treatment groups, the graded data was tested for significance in relation to the control group using Mann-Whitney U-testing (significance level: 5%), while the total values for positive grades were tested for significance with the control group using Fisher’s exact one-sided testing (significance level: 5%).For the other data, the values obtained for each individual or the mean values for each litter were used as single samples, and these samples were compared with the values within the satellite group or within the other groups. Where two groups were used in the analysis, F-testing was performed first, followed by Student t-testing if no significant differences were observed. If a significant difference was observed in the F-testing, Aspin-Welch testing was performed. When three or more groups were used in the analysis, the Bartlett method was used first in order to test for uniformity of variance in each group (significance level: 5%).If the variance was uniform, one-way analysis of variance (significance level: 5%) was performed. If a significant difference was observed between groups, the Dunnett method was used to perform a multiple comparison (significance level: 5%). On the other hand, if the variance in any of the groups was 0 and if the variance was not uniform, Kruskal-Wallis rank testing (significance level: 5%) was performed. If a significant difference was observed between groups, the Dunnett testing method was used to perform a multiple comparison (significance level: 5%).
- Reproductive indices:
- Copulation index, Fertility index, Gestation index, Imlantation index, Delivery index.
- Offspring viability indices:
- Birth index, Live birth index, Viability index.
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Other effects:
- no effects observed
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- Estrous cycle: no treatment related effect on incidence and length of estrous cycle
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Reproductive performance: No significant differences were observed between the control group and any of the treatment groups in impregnation rate, number of days to copulation or number of estrous during this period. No significant differences were observed for corpus luteum count, implantation count or implantation rate between control and treated groups.
Systemic toxicity details for parental animals are described at 7.5.1 Repeated dose toxicity: oral section. - Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: There were no effects related to test substance treatment.
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- not examined
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: There were no effects related to test substance treatment.
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- Under the study conditions, the NOAEL for fertility and fetal toxicity of the substance in rats was determined to be greater than 1000 mg/kg bw/day.
- Executive summary:
A study was conducted to determine the repeated dose toxicity of the read-across substance CAS 7299 -99 -2 in rats according to OECD Guideline 422, in compliance with GLP. A combined repeated dose-reproductive developmental screening study was conducted in rats in which the test substance was administered to groups of 12 animals per sex through oral gavage at dose levels of 100, 300 and 1000 mg/kg bw/day for 42 days (males) or 42 -54 days (for females). Males and females were co-habited in 1:1 ratio in the cages during the dosing period for a period of 2 weeks till there is proof of pregnancy. Mortality, clinical signs, food consumption and body weight measurements were performed on a regular basis during the dosing period. After the scheduled necropsy of the pregnant females, reproductive and fetal developmental parameters were examined. Apart from few non-treatment related effects, no adverse effects were observed in any of the treated groups. Under the study conditions, the NOAEL for fertility and fetal toxicity of the substance in rats was determined to be greater than 1000 mg/kg bw/day (MHLW, 2005).
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Toxicity to reproduction: other studies
Additional information
A study was conducted to determine the repeated dose toxicity of the read-across substance CAS 7299 -99 -2 in rats according to OECD Guideline 422, in compliance with GLP. A combined repeated dose-reproductive developmental screening study was conducted in rats in which the test substance was administered to groups of 12 animals per sex through oral gavage at dose levels of 100, 300 and 1000 mg/kg bw/day for 42 days (males) or 42 -54 days (for females). Males and females were co-habited in 1:1 ratio in the cages during the dosing period for a period of 2 weeks till there is proof of pregnancy.Mortality, clinical signs, food consumption and body weight measurements were performed on a regular basis during the dosing period. After the scheduled necropsy of the pregnant females, reproductive and fetal developmental parameters were examined. Apart from few non-treatment related effects, no adverse effects were observed in any of the treated groups. Under the study conditions, the NOAEL for fertility and fetal toxicity of the substance in rats was determined to be greater than 1000 mg/kg bw/day (MHLW, 2005).
Justification for classification or non-classification
Based on the combined repeat dose-reproductive-developmental screening toxicity study with the read-across substance CAS 7299 -99 -2, no classification is warranted according to EU CLP (EC 1272/2008) criteria.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.